These results are in line with the European Society of Cardiology/European Atherosclerosis Society 2019 guidelines for the management of dyslipidemias to prevent cardiovascular disease, which recommend measuring ApoB in addition to LDL-C.87 The gene discussed is APOB; the disease is metabolic syndrome.